Literature DB >> 6467202

Effect of oxygen on misonidazole chemosensitization and cytotoxicity in vitro.

R T Mulcahy.   

Abstract

In order to assess the effect of oxygen on chemopotentiation by misonidazole (MISO), EMT-6/Ro tumor cells were exposed in vitro to combinations of CCNU and 1.0 mM MISO in culture medium equilibrated at various oxygen concentrations. The effect of oxygen on MISO cytotoxicity was similarly determined and compared with the relationship obtained for chemosensitization. MISO cytotoxicity and chemopotentiation were both oxygen sensitive, being maximal under anoxic conditions. Furthermore, the pattern of oxygen sensitivity was virtually identical for the two activities. These results suggest that a similar metabolic pathway, i.e., the oxygen-sensitive reduction of MISO to the nitroradical anion by cellular nitroreductases, is involved in the mechanism of both activities. The data further indicate that chemopotentiation can be expressed in cells treated at intermediate oxygen tensions. The implications of these findings with respect to the magnitude of chemopotentiation in vivo and the enhancement of normal tissue damage in animals treated with MISO and chemotherapy agents is discussed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6467202

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

1.  Potentiation of CCNU activity by misonidazole in metastases.

Authors:  D W Siemann; K L Alliet
Journal:  Clin Exp Metastasis       Date:  1987 Jan-Mar       Impact factor: 5.150

2.  Potentiation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea's toxicity in vitro by two new bioreductive agents.

Authors:  M V Papadopoulou; A Mainwaring; W D Bloomer
Journal:  Jpn J Cancer Res       Date:  1992-08

3.  Cytotoxic effect of misonidazole and cyclophosphamide on aerobic and hypoxic cells in a C3H mammary carcinoma in vivo.

Authors:  C Grau; S M Bentzen; J Overgaard
Journal:  Br J Cancer       Date:  1990-01       Impact factor: 7.640

Review 4.  SR 4233 (tirapazamine): a new anticancer drug exploiting hypoxia in solid tumours.

Authors:  J M Brown
Journal:  Br J Cancer       Date:  1993-06       Impact factor: 7.640

5.  Modulation of the hypoxic toxicity and binding of misonidazole by glucose.

Authors:  L L Ling; R M Sutherland
Journal:  Br J Cancer       Date:  1986-12       Impact factor: 7.640

6.  Dependence of misonidazole binding on factors associated with hypoxic metabolism.

Authors:  L L Ling; R M Sutherland
Journal:  Br J Cancer       Date:  1987-10       Impact factor: 7.640

7.  Oxygen dependence of the cytotoxicity and metabolic activation of 4-alkylamino-5-nitroquinoline bioreductive drugs.

Authors:  B G Siim; G J Atwell; W R Wilson
Journal:  Br J Cancer       Date:  1994-10       Impact factor: 7.640

8.  Chemosensitization by misonidazole in CCNU-treated spheroids and tumours.

Authors:  R E Durand; D J Chaplin
Journal:  Br J Cancer       Date:  1987-08       Impact factor: 7.640

9.  Vascular perfusion and hypoxic areas in RIF-1 tumours after photodynamic therapy.

Authors:  I P van Geel; H Oppelaar; P F Rijken; H J Bernsen; N E Hagemeier; A J van der Kogel; R J Hodgkiss; F A Stewart
Journal:  Br J Cancer       Date:  1996-02       Impact factor: 7.640

10.  Oxygen dependence for chemosensitization by misonidazole.

Authors:  L Roizin-Towle; E J Hall; J P Pirro
Journal:  Br J Cancer       Date:  1986-12       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.